UVRAG blocking peptide product blogThe UVRAG uvrag (Catalog #MBS9223517) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.
The UVRAG uvrag product has the following accession number(s) (GI #20140879) (NCBI Accession #Q9P2Y5.1) (Uniprot Accession #Q9P2Y5). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Cellular Location: Late endosome. Lysosome. Early endosome. Note: Colocalizes with RAB9-positive compartments involved in retrograde transport from late endosomes to trans-Golgi network. Colocalization with early endosomes is only partial. Tissue Location: Highly expressed in brain, lung, kidney and liver. The following patways have been known to be associated with this gene. Carcinoma, Hepatocellular, Cell Transformation, Neoplastic, Heart Diseases, Kidney Diseases, Liver Diseases, Liver Neoplasms, Necrosis, Neoplasm Metastasis, Nervous System Diseases, Nervous System Malformations are some of the diseases may be linked to UVRAG Antibody (C-term) Blocking Peptide. Brain, Embryonic Tissue, Heart, Kidney, Liver, Lung, Mouth, Muscle, Skin, Stomach tissues are correlated with this protein. UVRAG also interacts with the following gene(s): AMBRA1, ATG14, BAX, BECN1, PIK3C3, PIK3R4, SH3GLB1, VPS16, VPS18.